Ajanta Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
AJANTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Ajanta Pharma has informed the stock exchanges that the trading window for dealing in its securities will remain closed from Wednesday, 1st April 2026 until 48 hours after the declaration of financial results for the quarter and year ended 31st March 2026. This is a routine compliance measure under SEBI's Prohibition of Insider Trading Regulations, 2015 and the company's own insider code of conduct. The closure prevents insiders, including directors and employees, from trading in the stock while they may have access to unpublished price-sensitive information ahead of the upcoming Q4 and FY26 results announcement. The communication was signed by Gaurang Shah, Sr. VP – Legal & Company Secretary, and filed on 26th March 2026.
No direct impact on shareholders or stock price. This is a standard regulatory filing. However, it signals that the company's Q4 and FY26 financial results are likely due in the coming weeks, which could be a catalyst for stock movement depending on the numbers reported.